News

Amgen assumed at Neutral from Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Carter Gould downgraded Amgen (AMGN) to Neutral from Overweight with a price target of $305, down from $340, as the ...
Amgen downgraded to Neutral from Overweight at Cantor Fitzgerald
Cantor Fitzgerald downgraded Amgen (AMGN) to Neutral from Overweight.Stay Ahead of the Market: Discover outperforming stocks and invest ...